The vaccine offers protection against all four strains of the dengue virus and is approved for people aged four to 60, irrespective of whether they've had dengue before, meaning no prior testing is required before vaccination.

DCGI clears Takeda's QDENGA, India's first-ever dengue vaccine: Full details inside

japan-takeda-biopharmaceuticals

Japan Takeda Biopharmaceuticals, News on Japan Takeda Biopharmaceuticals, stories on Japan Takeda Biopharmaceuticals, articles on Japan Takeda Biopharmaceuticals, Japan Takeda Biopharmaceuticals stories at Wion, Japan Takeda Biopharmaceuticals news, Japan Takeda Biopharmaceuticals latest news

japan takeda-biopharmaceuticals

DCGI clears Takeda's QDENGA, India's first-ever dengue vaccine: Full details inside